C12N 2710/10134
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2710/10134 (Use of virus or viral component as vaccine) appears on 9 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 9
- Assignees
- 13
- Inventors
- 30
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 2 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 2 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant adeno-associated virus capsids with enhanced human pancreatic tropism11 Nov 2025US 12,467,065 B2The Board of Trustees of the Leland Stanford Junior University
- tFIBER protein fragment of avian egg drop syndrome virus and vaccine composition prepared thereof, preparation method and use14 Oct 2025US 12,440,551 B2Pulike Biological Engineering, Inc.
- Recombinant adeno-associated virus capsids with enhanced human pancreatic tropism21 Mar 2023US 11,608,510 B2The Board of Trustees of the Leland Stanford Junior University
- Prophylactic vaccine against egg drop syndrome (EDS)9 Apr 2019US 10,253,072 B2KM Biologics Co., Ltd.
- Vaccine compositions comprising a saponin adjuvant4 Dec 2018US 10,143,745 B2GlacoSmithKline Biologicals, S.A.
- Neddylation-activating enzyme inhibitors as viral sensitizers and uses thereof15 Jan 2026US 2026/0015592 A1Ottawa Hospital Research Institute
- Or2l13 agonists to treat cvd with dysregulated platelet activation4 Apr 2024US 2024/0108591 A1The Cleveland Clinic Foundation
- Novel recombinant adeno-associated virus capsids with enhanced human pancreatic tropism28 Sep 2023US 2023/0304039 A1The Board of Trustees of the Leland Stanford Junior University
- Tfiber protein fragment of avian egg drop syndrome virus and vaccine composition prepared thereof, preparation method and use25 Aug 2022US 2022/0265811 A1Pulike Biological Engineering, Inc.
- Novel recombinant adeno-associated virus capsids with enhanced human pancreatic tropism23 Jan 2020US 2020/0024616 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents
- Nucleotidic sequence coding the surface antigen of the hepatitis B virus, vector containing said nucleotidic sequence, process allowing the obtention thereof and antigen obtained thereby62US 4,428,941 AInstitut National de la Sante et de la Recherche Medicale · 1984
- Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them16US 3,962,424 ARecherche et Industrie Therapeutiques (R.I.T.) · 1976
- Vaccine compositions comprising a saponin adjuvant3US 10,039,823 B2Glaxosmithkline Biologicals SA · 2018
- Combined vaccine2US 4,537,768 ARoussel Uclaf · 1985
- Vaccine compositions comprising a saponin adjuvant1US 10,143,745 B2GlacoSmithKline Biologicals, S.A. · 2018